In view of the above situation, it is assumed that sodium butyrate has a regulatory effect on irritable bowel syndrome, and the purpose is to analyze the effect of sodium butyrate on IRAK1 at the cellular level. This evidence concerns the gene IRAK1 and irritable bowel syndrome.